In addition, we previously reported that combined inactivation of Dnmt3a and Dnmt3b results in the development of CLL and peripheral T cell lymphoma (PTCL) [16], however the molecular basis of PTCL is poorly understood. The gene discussed is DNMT3A; the disease is peripheral T-cell lymphoma, not otherwise specified.